Medicenna Therapeutics Corp.
NASDAQ:MDNA
0.157 (USD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 9.304 | 14.716 | 10.87 | 5.87 | 3.018 | 5.09 | 4.229 | 0.771 | 0.001 | 0.001 |
| General & Administrative Expenses
| 6.994 | 7.72 | 6.485 | 2.493 | 2.209 | 2.997 | 4.016 | 0.47 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6.994 | 7.72 | 6.485 | 2.493 | 2.209 | 2.997 | 4.016 | 0.47 | 0 | 0 |
| Other Expenses
| 0.005 | 0.037 | 0.04 | -0.117 | -0.499 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 16.303 | 22.473 | 17.395 | 8.245 | 4.727 | 7.425 | 7.698 | 1.2 | 0.001 | 0.001 |
| Operating Income
| -16.303 | -22.3 | -17.187 | -8.206 | -4.727 | -7.381 | -7.665 | -1.2 | -0.001 | -0.001 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 6.255 | -0.104 | 0.106 | -0.032 | 0.019 | -0.041 | -1.717 | -0.134 | -0 | -0 |
| Income Before Tax
| -10.048 | -22.577 | -17.289 | -8.277 | -4.708 | -7.465 | -7.631 | -1.334 | -0.001 | -0.001 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -11.595 | 0.069 | -0.106 | 0.032 | 0.019 | 0.041 | 0 | 0 | 0 | -0 |
| Net Income
| 1.547 | -22.646 | -17.183 | -8.309 | -4.708 | -7.465 | -7.631 | -1.334 | -0.001 | -0.001 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.024 | -0.42 | -0.35 | -0.26 | -0.18 | -0.31 | -0.45 | -0.083 | -0.053 | -0.049 |
| EPS Diluted
| 0.024 | -0.42 | -0.35 | -0.26 | -0.18 | -0.31 | -0.45 | -0.083 | -0.053 | -0.049 |
| EBITDA
| -16.299 | -22.435 | -17.147 | -8.237 | -4.72 | -7.371 | -7.659 | -1.198 | -0.001 | -0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |